Biotech Investors & VC Firms in United Kingdom
137 firms in this list, with a median first check of $500K. 8 of them lead rounds. Generated from verified public data and updated continuously.
PhotonVentures
BreukelenSeed–Series A$1.1M – $2.7M
7 people
Seroba Life Sciences
DublinSeed–Late Stage$540K – $7.6M
7 people
University of Cambridge Enterprise
CambridgeSeed–Late Stage
10 people
ACT Venture Capital
DublinSeed–Series B$1.1M – $16.2M
6 people
Elmirate Capital
DubaiSeed–Late Stage$15M – $150M
Midven Ltd.
ManchesterSeed–Late Stage$25.4K – $635K
6 people
Monograph Capital Partners
San FranciscoSeed–Series A
9 people
Nina Capital
BarcelonaPre-Seed–Series A$216K – $1.6M
6 people
Northern Gritstone
ManchesterSeed–Series B
9 people
Crista Galli Ventures
LondonSeed–Series A
2 people
AMR Action Fund
BostonSeed–Series B
8 people
Backed
LondonSeed$540K – $2.7M
5 people
HEARTFELT_
BerlinPre-Seed–Series A
8 people
Innovation Nest
KrakowSeed–Series A$108K – $1.1M
5 people
Sectoral Asset Management
MontrealSeries A–Late Stage
8 people
Ada Ventures
LondonPre-Seed–Seed$317.5K – $1.3M
3 people
AdBio partners
ParisSeed–Series A
7 people
Astellas Venture Management LLC
South San FranciscoSeed–Series B$200K – $5M
4 people
Forepont Capital Partners
New YorkSeed–Late Stage
7 people
Metavallon VC
AtticaPre-Seed–Series A$540K – $1.6M
4 people
Onsight Ventures
InnsbruckSeed–Series A$216K – $2.2M
4 people
Oxford Technology Management
Henley-on-ThamesSeed–Series A$127K – $2.5M
4 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
VIVES Partners
WavreSeed–Series B$108K – $7.6M
4 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.